跳至主要内容
临床试验/NCT06000683
NCT06000683已完成不适用

Empowering Patients' Lung Cancer Screening Uptake (Empower LCS)

University of California, Irvine7 个研究点 分布在 1 个国家目标入组 79 人开始时间: 2023年10月13日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
79
试验地点
7
主要终点
Order of LDCT

研究概览

简要总结

Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test the effect of a a multi-level intervention on ordering LDCT within 6 months after patient enrollment. Our proposed intervention includes (1) Primary care provider notifications of patients' LCS eligibility; (2) patients' education ; (3) patients' referral to financial navigation resources; and (4) patients' reminder to discuss LCS during PCP visit.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients' Inclusion Criteria:
  • Aged 50- 80 years of age.
  • Be able to Speak English, Spanish, or Vietnamese
  • Must have a scheduled appointment with their Primary Care Providers within next one to three months.
  • The Scheduled PCP appointment is at any of the UCI Health primary care clinics in Orange County including two UCI federally qualified health centers
  • History of 20 pack year smoking history ( based on survey self report)
  • Current smoker or a former smoker who has quit smoking within the last 15 years (based on survey self report)

排除标准

  • Prior history of lung cancer
  • chest CT for any reason in the last 12 months based on self-report and UCI EMR
  • history of Alzheimer's disease or dementia
  • Providers' Inclusion Criteria:
  • Primary Care Providers whose patients were enrolled in the Empower LCS trial.
  • Received notifications about the eligibility of their patients for lung cancer screening.

研究组 & 干预措施

Empower LCS

Experimental

Patient will be given education material(addressing knowledge barriers); patients' referral to financial navigation resources (addressing health-related social risks); and patients' reminder to discuss LCS during PCP visit. Providers will also be notified of eligibility of their patients to receive LCS.

干预措施: Patient education (Behavioral)

Empower LCS

Experimental

Patient will be given education material(addressing knowledge barriers); patients' referral to financial navigation resources (addressing health-related social risks); and patients' reminder to discuss LCS during PCP visit. Providers will also be notified of eligibility of their patients to receive LCS.

干预措施: Referral to financial navigation resources (Behavioral)

Empower LCS

Experimental

Patient will be given education material(addressing knowledge barriers); patients' referral to financial navigation resources (addressing health-related social risks); and patients' reminder to discuss LCS during PCP visit. Providers will also be notified of eligibility of their patients to receive LCS.

干预措施: Patient Reminders (Behavioral)

Empower LCS

Experimental

Patient will be given education material(addressing knowledge barriers); patients' referral to financial navigation resources (addressing health-related social risks); and patients' reminder to discuss LCS during PCP visit. Providers will also be notified of eligibility of their patients to receive LCS.

干预措施: Provider Reminers (Behavioral)

结局指标

主要结局

Order of LDCT

时间窗: within 6 months of enrollment

Number of participants who were ordered screening with Low Dose Computed Tomographyorder (LDCT) within 6 months after enrollment, assessed with self-reported surveys or EMR data extraction.

次要结局

  • Receipt of LDCT(Within 6 months of enrollment)
  • LCS Discussion(within 6 months after enrollment)
  • Perceived Risk of Lung Cancer(At 6 months post-enrollment)
  • Perceived Severity of Lung Cancer(At 6 months post-enrollment)
  • Perceived Benefit of Lung Cancer Screening(At 6 months post-enrollment)
  • Perceived Barriers to Lung Cancer Screening(At 6 months post-enrollment)
  • Perceived Self-efficacy for Lung Cancer Screening(At 6 months post-enrollment)
  • Knowledge About Lung Cancer and Screening(At 6 months post-enrollment)
  • Providers' Perceived Barriers to Lung Cancer Screening(Baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gelareh Sadigh

Associate Professor

University of California, Irvine

研究点 (7)

Loading locations...

相似试验